Drug-induced coagulopathies: a real-world pharmacovigilance study using the FDA adverse event reporting system
Our findings indicate that multiple drugs are associated with an increased risk of coagulopathies. From the pharmacovigilance perspective, proactive analysis of these drugs aids in clinical monitoring and enhances risk identification of coagulopathies.
Authors
- Qian Xu (ORCID: https://orcid.org/0000-0003-0612-2319)
- Sixi Zhu (ORCID: https://orcid.org/0000-0001-9946-6705)
- Yanjun Lu
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2024-12-18
- DOI
- https://doi.org/10.3389/fphar.2024.1486422
- Citations
- 5
- Primary Topic
- Retinal and Optic Conditions
- Type
- article
- Field-Weighted Citation Impact
- 2.69